Skip to main content
CCCC
NASDAQ Life Sciences

Officer Files Intent to Sell Over 100,000 Shares Following Option Exercise

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
7
Price
$3.521
Mkt Cap
$350.306M
52W Low
$1.085
52W High
$3.82
Market data snapshot near publication time

summarizeSummary

An officer of C4 Therapeutics has filed a Form 144 to sell 101,175 shares, valued at approximately $378,849, following a stock option exercise.


check_boxKey Events

  • Officer Files Intent to Sell Shares

    Jolie M. Siegel, an Officer, filed a Form 144 indicating an intent to sell 101,175 shares of common stock.

  • Significant Value of Proposed Sale

    The proposed sale has an approximate market value of $378,849.35.

  • Follows Stock Option Exercise

    The shares to be sold were acquired through a stock option exercise on the same day as the proposed sale date.

  • Minor Dilution Relative to Outstanding Shares

    The shares represent approximately 0.10% of the company's total outstanding shares.


auto_awesomeAnalysis

Jolie M. Siegel, an Officer of C4 Therapeutics, has filed a Form 144 indicating an intent to sell 101,175 shares of common stock, valued at approximately $378,849. This proposed sale follows the exercise of stock options. While common for liquidity or tax purposes, a reduction in direct insider ownership by an officer can be perceived as a slight negative signal, especially coming after the company recently announced strong financial results and a successful capital raise that extended its cash runway through 2028.

At the time of this filing, CCCC was trading at $3.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $350.3M. The 52-week trading range was $1.09 to $3.82. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CCCC - Latest Insights

CCCC
Apr 09, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
9
CCCC
Apr 09, 2026, 6:59 AM EDT
Source: GlobeNewswire
Importance Score:
9
CCCC
Mar 25, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
CCCC
Mar 09, 2026, 4:20 PM EDT
Filing Type: 144
Importance Score:
7
CCCC
Feb 26, 2026, 7:49 AM EST
Filing Type: 10-K
Importance Score:
8